Medical Condition

inflammatory bowel diseases

Total Trials

14

Recruiting Now

14

Trial Phases

Phase 4, Phase 2, Phase 1

ClinicalMetric tracks all active clinical trials for inflammatory bowel diseases sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — inflammatory bowel diseases Clinical Trials

How many clinical trials are currently recruiting for inflammatory bowel diseases?

ClinicalMetric currently tracks 14 actively recruiting clinical trials for inflammatory bowel diseases, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 14. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.

What trial phases are available for inflammatory bowel diseases?

inflammatory bowel diseases research spans Phase 1 (1 trial), Phase 2 (1 trial), Phase 4 (2 trials). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.

How do I find out if I qualify for a inflammatory bowel diseases clinical trial?

Eligibility criteria for inflammatory bowel diseases trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.

Trial Phases

Phase 1

Phase 2

Phase 4

Top Sponsors

Shanghai Institute of Acupuncture, Moxibustion and Meridian 1 trial

Massachusetts General Hospital 1 trial

Assistance Publique - Hôpitaux de Paris 1 trial

Belgian Inflammatory Bowel Disease Research and Development (BIRD) VZW 1 trial

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 1 trial

Recruiting Clinical Trials

NCT06553053

Recruiting

Acupuncture Reduces Relapse in Patients With Crohn's Disease: a Superiority Trial

Shanghai Institute of Acupunct...

View Trial →

NCT05332639

Recruiting

Personalized Risk Estimation for Crohn's Disease (PRE-Crohn's): Implementation and Feasibility

Massachusetts General Hospital

View Trial →

NCT05704413

Recruiting

Digestive Biobank for Exploring Microbiota-host Interactions

Assistance Publique - Hôpitaux...

View Trial →

NCT06113913 Phase 4

Recruiting

Subcutaneous Infliximab After A Previous Intravenous Dose Optimization

Belgian Inflammatory Bowel Dis...

View Trial →

NCT06584162 Phase 4

Recruiting

Subcutaneous Interval Lengthening of Vedolizumab for Economic Research

Academisch Medisch Centrum - U...

View Trial →

NCT06550310

Recruiting

Nutrition and Clinical Outcomes in IBD

Barts & The London NHS Trust

View Trial →

NCT06604728

Recruiting

Effectiveness and Tolerance of IV vs SC Biological Drugs in Gastrointestinal Diseases

Fondazione Policlinico Univers...

View Trial →

NCT05575505 Phase 2

Recruiting

Phosphodiesterase Inhibitors, Pentoxifylline, as Adjunctive Therapy in Patients With Ulcerative Colitis.

Prevalence of Non-Alcoholic Fatty Liver Disease in Inflammatory Bowel Disease Patients

Centre Hospitalier Universitai...

View Trial →

NCT07401680 Phase 1

Recruiting

Fecal Microbiota Transplantation in an Expanded Ulcerative Colitis Population

University of Alberta

View Trial →

NCT06616714

Recruiting

Faesiblity and Safety of Endoscopic sLeeve gastrOplasty in Patients With obEsity and nflammatoRy Bowel Disease

Genome Analysis Across Populations in Inflammatory Bowel Disease

Mount Sinai Hospital, Canada

View Trial →

NCT04617184

Recruiting

Registry and Biorepository for IBD in Central Texas

University of Texas at Austin

View Trial →

NCT06548399

Recruiting

Longitudinal Study on Bacterial Production of LPC and LPA in Patients With Inflammatory Bowel Disease

Related Conditions

ulcerative colitis (7) crohn disease (6) crohn s disease relapse (1) crohn colitis (1) crohn s ileocolitis (1) crohn s gastritis (1) crohn s jejunitis (1) crohn s duodenitis (1) crohn s esophagitis (1) colorectal cancer (1) indeterminate colitis (1) malnutrition (1)

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology